Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
(2012) 7:e39307
Selective androgen receptor modulators (SARMs), such as enobosarm (GTx-024), increase lean mass and may improve function, but phase III results have been mixed and no agent has regulatory approval for sarcopenia [71]
The choice between them isn't about which one is "stronger." It's about which one is the right tool for a specific research question
Realistically, were looking at 20312032 for availability in Bulgaria, assuming everything goes smoothly with Phase 3 results and regulatory submissions
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
